Quality as a Strategic Pillar in Lentiviral Vector Manufacturing
VIVEbiotech’s Chief Quality Officer, Tathiane Castro, shares the company’s quality driven vision supporting robust, reliable and regulatory aligned lentiviral vector production.
At VIVEbiotech, quality is not only a regulatory requirement—it is the foundation that shapes how we develop, manufacture and deliver lentiviral vectors for advanced therapies. This commitment guides every decision, every process and every partnership.
In a new video, our Chief Quality Officer, Tathiane Castro, provides insight into how VIVEbiotech has built a comprehensive and rigorous quality framework designed to ensure consistency, compliance and patient safety. Our quality systems span the entire product lifecycle and align with the highest international standards, including EMA and FDA expectations.
This approach is particularly crucial for in vivo lentivirus applications, where precision, product integrity and process control play a decisive role in clinical outcomes. Supported by a strong culture of scientific excellence and continuous improvement, our teams work to ensure that each manufacturing step contributes to robust and reliable results.
Quality is, and will continue to be, a strategic pillar that enables us to support our partners in advancing innovative therapies toward patients with confidence.
To learn more about our quality‑driven approach, you can watch the full video here.